Doctors thought this heart breakthrough was coming. Then everything changed — Live Feedhttps://www.live-feeds.com/feed/doctors-thought-this-heart-breakthrough-was-coming-then-everything-changedContinuously updated, source-cited coverage. Novartis Heart Drug Fails Late-Stage Trialhttps://www.live-feeds.com/feed/doctors-thought-this-heart-breakthrough-was-coming-then-everything-changedhttps://www.live-feeds.com/feed/doctors-thought-this-heart-breakthrough-was-coming-then-everything-changed#u64716Fri, 11 Sep 2026 05:16:52 +0000A late-stage trial for a Novartis cholesterol drug failed to meet its target, sparking concerns across the emerging heart disease medication sector. The setback has impacted investor confidence, leading to a drop in Novartis shares and casting doubt on a multibillion-dollar industry race. Cardiologists expressed shock at the result, as the failure challenges hopes for a new class of heart breakthroughs. The outcome has also coincided with significant market volatility for other biotech firms, including a historic one-day stock decline for Amgen.Why it mattersPharmaceutical companies are compet